Giulia Puliatti

Dr. Giulia Puliatti

Università Cattolica del Sacro Cuore, Rome, Lazio, Italy
orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2023 in Cellular and Molecular Life Sciences
Verified
Journal Article
Open access
PDF file
DPDomenica Donatella Li Puma
Domenica Donatella Li Puma
CCClaudia. Colussi
Claudia. Colussi
BBBruno Bandiera
Bruno Bandiera
GPGiulia Puliatti
Giulia Puliatti
MRMarco Rinaudo
Marco Rinaudo
Claudio GrassiClaudio Grassi
Claudio Grassi
Extensive research provides evidence that neuroinflammation underlies numerous brain disorders. However, the molecular mechanisms by which inflammatory mediators determine synaptic and cognitive dysfunction occurring in neurodegenerative diseases (e.g., Alzheimer’s disease) are far from being fully understood. Here we investigated the role of interleukin 1β (IL-1β), and the molecular cascade downstream the activation of its receptor, to the synaptic dysfunction occurring in the mouse model of multiple Herpes simplex virus type-1 (HSV-1) reactivations within the brain. These mice are characterized by neuroinflammation and memory deficits associated with a progressive accumulation of neurodegenerative hallmarks (e.g., amyloid-β protein and tau hyperphosphorylation). Here we show that mice undergone two HSV-1 reactivations in the brain exhibited increased levels of IL-1β along with significant alterations of: (1) cognitive performances; (2) hippocampal long-term potentiation; (3) expression synaptic-related genes and pre- and post-synaptic proteins; (4) dendritic spine density and morphology. These effects correlated with activation of the epigenetic repressor MeCP2 that, in association with HDAC4, affected the expression of synaptic plasticity-related genes. Specifically, in response to HSV-1 infection, HDAC4 accumulated in the nucleus and promoted MeCP2 SUMOylation that is a post-translational modification critically affecting the repressive activity of MeCP2. The blockade of IL-1 receptors by the specific antagonist Anakinra prevented the MeCP2 increase and the consequent downregulation of gene expression along with rescuing structural and functional indices of neurodegeneration. Collectively, our findings provide novel mechanistic evidence on the role played by HSV-1-activated IL-1β signaling pathways in synaptic deficits leading to cognitive impairment.

16 March 2022 in Neuropathology and Applied Neurobiology
Verified
Journal Article
Open access
DPDomenica Donatella Li Puma
Domenica Donatella Li Puma
Cristian RipoliCristian Ripoli
Cristian Ripoli
GPGiulia Puliatti
Giulia Puliatti
FPFrancesco Pastore
Francesco Pastore
Giacomo LazzarinoGiacomo Lazzarino
Giacomo Lazzarino
Claudio GrassiClaudio Grassi
Claudio Grassi
Aims: Several studies reported that astrocytes support neuronal communication by the release of gliotransmitters, including ATP and glutamate. Astrocytes also play a fundamental role in buffering extracellular glutamate in the synaptic cleft, thus limiting the risk of excitotoxicity in neurons. We previously demonstrated that extracellular tau oligomers (ex‐oTau), by specifically targeting astrocytes, affect glutamate‐dependent synaptic transmission via a reduction in gliotransmitter release. The aim of this work was to determine if ex‐oTau also impair the ability of astrocytes to uptake extracellular glutamate, thus further contributing to ex‐oTau‐dependent neuronal dysfunction.Methods: Primary cultures of astrocytes and organotypic brain slices were exposed to ex‐oTau (200 nM) for 1 h. Extracellular glutamate buffering by astrocytes was studied by: Na+ imaging; electrophysiological recordings; high‐performance liquid chromatography; Western blot and immunofluorescence. Experimental paradigms avoiding ex‐oTau internalisation (i.e. heparin pre‐treatment and amyloid precursor protein knockout astrocytes) were used to dissect intracellular vs extracellular effects of oTau.Results: Ex‐oTau uploading in astrocytes significantly affected glutamate‐transporter‐1 expression and function, thus impinging on glutamate buffering activity. Ex‐oTau also reduced Na‐K‐ATPase activity because of pump mislocalisation on the plasma membrane, with no significant changes in expression. This effect was independent of oTau internalisation and it caused Na+ overload and membrane depolarisation in ex‐oTau‐targeted astrocytes.Conclusions: Ex‐oTau exerted a complex action on astrocytes, at both intracellular and extracellular levels. The net effect was dysregulated glutamate signalling in terms of both release and uptake that relied on reduced expression of glutamate‐transporter‐1, altered function and localisation of NKA1A1, and NKA1A2. Consequently, Na+ gradients and all Na+‐dependent transports were affected.

Verified
Journal Article
Open access
PDF file
CGClaudia Guerriero
Claudia Guerriero
GPGiulia Puliatti
Giulia Puliatti
TMTamara Di Marino
Tamara Di Marino
Ada Maria TataAda Maria Tata
Ada Maria Tata
Background: Dimethyl fumarate (DMF) is a drug currently in use in oral therapy for the treatment of relapsing-remitting multiple sclerosis (RRMS) due to its immunomodulatory and neuroprotective effects. The mechanisms by which DMF exerts its therapeutic effects in MS and in particular its influence on the oligodendrocytes (OLs) survival or differentiation have not yet been fully understood. Methods: Characterization of Oli neu cells was performed by immunocytochemistry and RT-PCR. The effect of DMF on cell proliferation and morphology was assessed by MTT assay, trypan blue staining, RT-PCR and Western blot analysis. The antioxidant and anti-inflammatory properties of DMF were analysed by ROS detection through DCFDA staining and lipid content analysis by Oil Red O staining and TLC. Results: DMF has been observed to induce a slowdown of cell proliferation, favoring the oligodendrocyte lineage cells (OLCs) differentiation. DMF has an antioxidant effect and is able to modify the lipid content even after the LPS-mediated inflammatory stimulus in Oli neu cells. Conclusions: The results obtained confirm that DMF has anti-inflammatory and antioxidant effects also on Oli neu cells. Interestingly, it appears to promote the OLCs differentiation towards mature and potentially myelinating cells.

29 September 2025 in Advanced Materials
Verified
Journal Article
Open access
Antonio BuonerbaAntonio Buonerba
Antonio Buonerba
GPGiulia Puliatti
Giulia Puliatti
DPDomenica Donatella Li Puma
Domenica Donatella Li Puma
BBBruno Bandiera
Bruno Bandiera
BCBeatrice Cannata
Beatrice Cannata
RPRoberto Piacentini
Roberto Piacentini
“A Trojan Horse for Lithium Delivery” . Lithium has important pharmacological applications, although its use is severely limited due to its narrow therapeutic window of administrable concentrations. This study presents a novel nanocarrier for this metal cation based on glutathione‐stabilized gold nanoparticles (LiG‐AuNPs), which enable targeted release of lithium. LiG‐AuNPs are easily synthesized, with dimensions of ≈2 nm, with a lithium loading of 2 wt%. These particles show a tendency to aggregate and a narrow size distribution. Aggregates of LiG‐AuNPs (a‐LiG‐AuNPs) are non‐toxic to cells at concentrations lower than 2 mg mL −1 and are rapidly internalized into cells, where they release lithium in the cytosol through cation exchange, effectively modulating Glycogen Synthase Kinase‐3 (GSK‐3β) activity, especially the β isoform. Administration of a‐LiG‐AuNPs in murine models increased the inhibitory phosphorylation of GSK‐3β at Ser9. Intranasal administration of a‐LiG‐AuNPs modulated GSK‐3β activity in the brain, particularly in the hippocampus, without significantly altering plasma lithium levels, even when the administration lasted several months. LiG‐AuNPs thus represent a powerful tool for the targeted administration of lithium, enhancing its therapeutic effects in modulating GSK‐3β. They have potential applications for treating illnesses depending on GSK‐3β (hyper)activation, such as mood disorders, Alzheimer's disease, and viral infections.

20 June 2025 in Cells
Verified
Journal Article
Open access
PDF file
CGClaudia Guerriero
Claudia Guerriero
GPGiulia Puliatti
Giulia Puliatti
TMTamara Di Marino
Tamara Di Marino
GSGiulia Scanavino
Giulia Scanavino
Carlo MateraCarlo Matera
Carlo Matera
Ada Maria TataAda Maria Tata
Ada Maria Tata
α7 nAChRs are known to modulate several physiological and pathological functions in glial cells, and their selective activation might have anti-inflammatory effects in the central and peripheral nervous system. OL progenitors (OPCs) respond to cholinergic stimuli via muscarinic receptors that are mainly involved in the modulation of their proliferation. Conversely, the role of nicotinic receptors, particularly α7 nAChRs, has been poorly investigated. In this study, we evaluated the expression of α7 nAChRs in a model of OPCs (Oli neu) and the potential effects mediated by their selective activation. Methods: Oli neu cells were used as a murine immortalized OPCs model. The effects of α7 nAChRs stimulation on cell proliferation and survival were assessed by the MTT assay. RT-PCR and Western blot analysis were used to analyze the expression of α7 nAChRs and proliferative and differentiative markers (PCNA, MBP). LPS exposure was used to induce the environment in which the antioxidant and anti-inflammatory properties of α7 nAChRs were analyzed, evaluating NFR2 and TNF-α expression, ROS levels through DCFDA staining while Oil Red O staining was used for the analysis of lipid droplet content as a marker of cellular inflammation response. Results: The α7 nAChR is expressed both in OPCs and OLs, and its stimulation by the selective agonist ICH3 increases cell proliferation without modifying the OLs’ differentiation capability. Moreover, ICH3 showed anti-inflammatory and antioxidant effects against LPS exposure. Conclusions: The results herein obtained confirm the role of α7 nAChR in the modulation of neuroinflammatory processes as well as their protective effects on OLs.

15 January 2025 in Preprints.org
Verified
Preprint
Open access
PDF file
CGClaudia Guerriero
Claudia Guerriero
GPGiulia Puliatti
Giulia Puliatti
TMTamara Di Marino
Tamara Di Marino
GSGiulia Scanavino
Giulia Scanavino
Carlo MateraCarlo Matera
Carlo Matera
Ada Maria TataAda Maria Tata
Ada Maria Tata
Background: Oligodendrocytes (OLs) are highly sensitive to oxygen-reactive species produced during neuro-inflammation. α7 nAChRs are expressed in glial cells where they can modulate several physiological and pathological functions. OL progenitors (OPCs) respond to cholinergic stimuli via muscarinic receptors that are mainly involved in the modulation of their proliferation. Differently, the role of nicotinic receptors, in particular α7 nAChRs, has been poorly investigated. In this study, we evaluated the expression of α7 nAChRs in a model of OPCs (Oli neu) and the potential effects mediated by their selective activation. Methods: The effects of α7 nAChRs stimulation on cell proliferation and survival were assessed by the MTT assay. RT-PCR and Western blot analysis were used to analyse the expression of α7 nAChRs and proliferative and differentiative markers (PCNA, MBP). The antioxidant and anti-inflammatory properties of α7 nAChRs were analysed evaluating NFR2 expression and ROS levels through DCFDA staining while Oil Red O staining was used for lipid content analysis. Results: The α7 nAChR is expressed both in OPCs and OLs and its stimulation by the selective agonist ICH3 increases cell proliferation without modifying the OLs differentiation capability. Moreover, ICH3 showed anti-inflammatory and antioxidant effects against LPS exposure. Conclusions: The results herein obtained confirm the role of α7 nAChR in the modulation of neuroinflammatory processes as well as their protective effects on OLs